Elevance Health, Inc. ELV

Latest FY: 2025 Healthcare Healthcare Plans
Market Price $414.77
Market Cap $89.94B
P/E Ratio 16.45
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑12.5% YoY
$199.12B
3-Yr CAGR: 8.3%
Net Income ↓-5.3% YoY
$5.66B
Net Margin: 2.8%
Free Cash Flow ↓-30.3% YoY
$3.17B
FCF Yield: 3.53%
EPS (Diluted) ↓-1.8% YoY
$25.21
Basic: $25.28
Return on Equity Efficiency
12.9%
ROA: 4.7%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (ELV)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $84,863.0M $17,359.6M $2,469.8M $9.21 $2.60 1.81% $3,204.5M $2,620.9M
FY 2017 $90,039.4M +6.1% $16,825.0M $3,842.8M +55.6% $14.35 +55.8% $2.70 1.20% $4,184.8M $3,385.3M +29.2%
FY 2018 $92,105.0M +2.3% $19,446.0M $3,750.0M -2.4% $14.19 -1.1% $3.00 1.14% $3,827.0M $2,619.0M -22.6%
FY 2019 $104,213.0M +13.1% $24,026.0M $4,807.0M +28.2% $18.47 +30.2% $3.20 1.06% $6,061.0M $4,984.0M +90.3%
FY 2020 $121,867.0M +16.9% $28,457.0M $4,572.0M -4.9% $17.98 -2.7% $3.80 1.18% $10,688.0M $9,667.0M +94.0%
FY 2021 $138,639.0M +13.8% $29,007.0M $6,104.0M +33.5% $24.73 +37.5% $4.52 0.98% $8,364.0M $7,277.0M -24.7%
FY 2022 $156,595.0M +13.0% $31,015.0M $6,025.0M -1.3% $24.81 +0.3% $5.12 1.00% $8,399.0M $7,247.0M -0.4%
FY 2023 $171,340.0M +9.4% $33,820.0M $5,987.0M -0.6% $25.22 +1.7% $5.92 1.26% $8,061.0M $6,765.0M -6.7%
FY 2024 $177,011.0M +3.3% $33,622.0M $5,980.0M -0.1% $25.68 +1.8% $6.47 1.76% $5,808.0M $4,552.0M -32.7%
FY 2025 $199,125.0M +12.5% $33,671.0M $5,662.0M -5.3% $25.21 -1.8% $6.81 1.94% $4,290.0M $3,174.0M -30.3%
$

Valuation

Market Price $414.77
Market Cap $89.94B
Enterprise Value $112.34B
P/E Ratio 16.45
P/B Ratio 2.05
FCF Yield 3.53%
Dividend Yield 1.64%
Shares Outstanding 216,841,100
%

Profitability & Margins

Gross Margin 16.91%
Operating Margin 3.62%
Net Margin 2.84%
Return on Equity (ROE) 12.90%
Return on Assets (ROA) 4.66%
Asset Turnover 1.64x
Revenue 3-Yr CAGR 8.34%
🛡️

Financial Health & Liquidity

Current Ratio 1.54
Cash Ratio 0.23
Debt / Equity 0.727
Debt / Assets 0.263
Cash & Equivalents $9.49B
Total Debt $31.90B
Book Value / Share $202.37
💧

Cash Flow Efficiency

Operating Cash Flow $4.29B
Capital Expenditures (CapEx) $1.12B
Free Cash Flow $3.17B
OCF / Revenue 2.15%
FCF / Revenue 1.59%
FCF 3-Yr CAGR -24.06%
🏷️

Per Share Metrics

EPS (Diluted) $25.21
EPS (Basic) $25.28
Dividends / Share $6.81
Book Value / Share $202.37
EPS YoY Growth -1.83%
🏛️

Balance Sheet (FY 2025)

Total Assets $121.49B
Total Liabilities $77.47B
Stockholders' Equity $43.88B
Current Assets $63.00B
Current Liabilities $41.03B